Brentuximab Vedotin Clinical Trials
12 recruitingDrug
Phase 28Early Phase 11Phase 31Phase 41Phase 11
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
National Cancer Institute (NCI)1,875 enrolled403 locationsNCT05675410
Recruiting
Phase 2
Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment
Classic Hodgkin Lymphoma
City of Hope Medical Center23 enrolled1 locationNCT07275216
Recruiting
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Hodgkin Lymphoma
Takeda8 enrolled1 locationNCT05481437
Recruiting
Phase 4
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
Hodgkin Lymphoma
Takeda124 enrolled11 locationsNCT06831370
Recruiting
Phase 2
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell LymphomaAnn Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell LymphomaAnn Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma+1 more
M.D. Anderson Cancer Center31 enrolled1 locationNCT04745949
Recruiting
Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
Malignant MesotheliomaCD30-Positive Neoplastic Cells Present
M.D. Anderson Cancer Center55 enrolled1 locationNCT03007030
Recruiting
Phase 2
BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
Hodgkin LymphomaAdvanced Hodgkin Lymphoma
University of Miami48 enrolled1 locationNCT07002216
Recruiting
Phase 2
Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
Relapsed Classic Hodgkin Lymphoma
City of Hope Medical Center31 enrolled5 locationsNCT04561206
Recruiting
Phase 2
Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
Emory University46 enrolled2 locationsNCT05039073
Recruiting
Early Phase 1
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell LymphomaPeripheral T Cell LymphomaNK-Cell Leukemia
New York Medical College40 enrolled6 locationsNCT03719105
Recruiting
Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
Recurrent Follicular LymphomaRefractory Follicular Lymphoma
Joseph Tuscano23 enrolled1 locationNCT04587687
Recruiting
Phase 1Phase 2
Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse
DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland37 enrolled1 locationNCT03356054